Tel: | +86-21-31433387 |
+86-15618786686 | |
Email: | sales@rechemscience.com |
info@rechemscience.com | |
QQ: | 1369748377 |
Skype: | sales@rechemscience.com |
Cat.No. | Product name | Product Description |
R10013 | PF 04691502 | PF-04691502 is an ATP-competitive PI3K(α/β/δ/γ)/mTOR dual inhibitor with Ki of 1 |
R10014 | AKT inhibitor VIII (AKTI-1/2) | CAS NO.:612847-09-3Product Name:1-(1-(4-(6-Phenyl-1H-imidazo[4,5-g]quinoxalin-7- |
R10072 | GSK690693 | GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM |
R10493 | AKT inhibitor IV | |
R10529 | Perifosine(KRX-0401; NSC 639966; D21266) | Perifosine (KRX-0401) is a novel Akt inhibitor with IC50 of 4.7 μM in MM.1S cell |
R10554 | Ipatasertib;GDC-0068; RG7440 | Ipatasertib (GDC-0068) is a highly selective pan-Akt inhibitor targeting Akt1/2/ |
R10868 | MK-2206 dihydrochloride | MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM |